IHPC Tells Congress to Stop the FDA from Restricting Women’s Access to Estriol, and stresses the Importance of Consumer Education!
In late May 2008, IHPC sent a letter to Congress supporting House Concurrent Resolution 342 to stop the FDA from restricting women's access to bio-identical estriol by compounding pharmacies.
© 2013 Integrative Health Policy Consortium